BioNote, Inc.
KOSPI
₩4,760.00
-0.10%
Delayed · cached 15 min
Fair value analysis
377740
BioNote, Inc.
₩4,760.00
Close used for this calculation
₩1,480.04Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
32/100
Quality radar
Consensus fair value
₩1,480.04
Above FV▼ -68.9% against the close used
Model range ₩1,161.77 – ₩2,324.43
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩1,161.77Fair value₩1,480.04Bull₩2,324.43
FairClose
52-week traded range
52W low ₩4,365.0052W high ₩6,230.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
BioNote, Inc. closed at ₩4,760.00, 221.6% above the consensus fair value of ₩1,480.04 drawn from 3 valuation models.
Financial DNA score 32/100 — Weak.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩1,161.77
-75.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
EV/EBITDA
₩1,651.52
-65.3%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=16.71B
Dividend Discount (DDM)
₩2,324.43
-51.2%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=182.31, r=10%, g=2%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.